Five-year survival of patients with hilar cholangiocarcinoma: a single-center retrospective study
The 5-year survival rate of patients with hilar cholangiocarcinoma was 35.8% at Samsung Medical Center. Median survival was 40 months. N2 stage and tumor biology were factors affecting 5-year survival.
Authors
- Jin Seok Heo (ORCID: https://orcid.org/0000-0001-6767-2790)
- In Woong Han (ORCID: https://orcid.org/0000-0001-7093-2469)
- Sang Hyun Shin (ORCID: https://orcid.org/0000-0002-2533-4491)
- Hee Joon Kim (ORCID: https://orcid.org/0000-0002-8636-5726)
- Soo Yeun Lim (ORCID: https://orcid.org/0000-0002-6091-5064)
- Hyun Jeong Jeon (ORCID: https://orcid.org/0000-0002-5928-1375)
- Hongbeom Kim (ORCID: https://orcid.org/0000-0002-1595-0135)
- So Jeong Yoon (ORCID: https://orcid.org/0000-0001-5227-4490)
- HyeJeong Jeong (ORCID: https://orcid.org/0000-0003-0024-1659)
Institutions
- Chonnam National University (KR)
- Eulji University (KR)
- Korea University Medical Center (KR)
- Samsung Medical Center (KR)
- Kyungpook National University (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Annals of Surgical Treatment and Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4174/astr.2025.109.2.71
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sungkyunkwan University
- Korea Health Industry Development Institute
- Samsung